Vincit Biotech International Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Vincit Biotech International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijay Bankda and Kedarmal Bankda serve as directors at the Company.
- CIN/LLPIN
U51909MP2022PTC061970
- Company No.
061970
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vincit Biotech International?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Bankda  | Director | 25-Jul-2022 | Current |
| Kedarmal Bankda | Director | 25-Jul-2022 | Current |
Financial Performance and Corporate Structure Insights of Vincit Biotech International.
Enhance accessibility to Vincit Biotech International's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vincit Biotech International?
Unlock access to Vincit Biotech International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Syncom Formulations (India) LimitedActive 36 years 6 monthsVijay Bankda and Kedarmal Bankda are mutual person
Sante Biotech Private LimitedActive 2 years 5 monthsVijay Bankda and Kedarmal Bankda are mutual person
- Synmex Pharma Private LimitedActive 2 years 5 months
Vijay Bankda and Kedarmal Bankda are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vincit Biotech International?
Vincit Biotech International has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vincit Biotech International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vincit Biotech International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
